Skip to main content
Elsevier
View Cart
My account

Books in Life sciences

BooksJournals

    • Antimicrobial Therapeutics and Drug Discovery

      • 1st Edition
      • March 1, 2026
      • Chengyuan Liang + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 6 5 1 8 8
      • eBook
        9 7 8 0 4 4 3 3 6 5 1 9 5
      Antimicrobial Therapeutics and Drug Discovery is a comprehensive resource that provides an overview of antimicrobial drug discovery. It covers a wide spectrum of pathogenic organisms causing human infections, exploring alternative therapeutic strategies beyond traditional small molecule drugs. The contents in the book are structured into four parts, each focusing on a different aspect of antimicrobial drug discovery. From exploring viral and host targets, understanding antibiotic resistance mechanisms, to the potential of nanomedicine and computational approaches, the book offers a comprehensive view of the field. Employing a multidisciplinary approach, chapters discuss the importance of drug discovery for fungi, Mycobacteria, Mycoplasma, and parasites, and offers insights into innovative biomedical approaches and combination therapies. By bridging the gap between experimental research and practical application, Antimicrobial Therapeutics and Drug Discovery is a key reference for pharmacologists and pharmaceutical scientists working in academic and corporate research. Medicinal chemists and microbiologists will also benefit from the multidisciplinary coverage of the book.

    • AI and Data Science in Medical Research

      • 1st Edition
      • March 1, 2026
      • Olfa Boubaker
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 6 3 8 5
      • eBook
        9 7 8 0 4 4 3 2 7 6 3 9 2
      AI and Data Science in Medical Research focuses on the integration of AI and data science into medical research, highlighting their impact on drug discovery, medical imaging, diagnostics, and genomic medicine. The book addresses the acceleration of therapeutic compound discovery and optimization of drug development pipelines through AI. The volume also discusses advancements in medical imaging, including early disease detection and neuroimaging. Additionally, it covers the application of AI in genomic medicine, offering insights into personalized treatment strategies.The volume concludes with an examination of AI's role in public health surveillance, particularly in disease detection and epidemiological research.

    • Live Biotherapeutics: Advancing Microbial Medicine

      • 1st Edition
      • Volume 220
      • March 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 1 9 0 6
      • eBook
        9 7 8 0 4 4 3 4 3 1 9 1 3
      Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

    • Roadmap to Successful Digital Health Ecosystems

      • 2nd Edition
      • March 1, 2026
      • Evelyn Hovenga + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 4 0 7 3 1
      • eBook
        9 7 8 0 4 4 3 4 4 0 7 4 8
      Roadmap to Successful Digital Health Ecosystems: A Global Perspective, Second Edition explores the transformative integration of digital health technologies to enhance healthcare delivery and patient outcomes. This book provides a comprehensive overview of the evolving landscape of digital health, focusing on next-generation systems and the role of artificial intelligence in creating efficient healthcare ecosystems. The revised content covers topics such as regional implementation experiences, workforce management, and precision healthcare. New chapters highlight advancements in digital health technologies, case studies from Jamaica and Africa, and strategies for addressing fragmentation in healthcare systems. The book emphasizes ethical AI use and proactive, integrated healthcare approaches. For the academic audience, this revision serves as an essential resource, compiling cutting-edge research and practical applications that inform best practices in digital health. It equips researchers, educators, and practitioners with the knowledge needed to navigate the complexities of digital health ecosystems and drive innovation in their fields.

    • Growth Hormone and Related Disorders: From Clinics to Diagnosis

      • 1st Edition
      • Volume 131
      • March 1, 2026
      • English
      • Hardback
        9 7 8 0 4 4 3 4 3 1 7 2 2
      • eBook
        9 7 8 0 4 4 3 4 3 1 7 3 9
      An excess of growth hormone (GH) results in accelerated growth and in childhood, the clinical manifestation is gigantism. When GH excess has its onset after epiphyseal fusion at puberty, the overgrowth of soft tissue and bone results in acromegaly. This volume covers various topics related to growth hormone and its associated disorder when there is a GH excess, including their pathophysiology, clinical presentation and diagnosis. The volume includes a total of 8 chapters that provide a comprehensive overview of the synthesis, regulation, and various disorders related to growth hormone, including acromegaly and gigantism. The chapters have been written by experts in the field of pituitary tumors.

    • Chalcones

      • 1st Edition
      • March 1, 2026
      • Simone Carradori + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 3 8 1 2 7
      • eBook
        9 7 8 0 4 4 3 4 3 8 1 3 4
      Chalcones: From Drug Discovery to Pharmaceutical Applications serves as a comprehensive reference on chalcones, detailing their natural occurrence, synthetic methods, and therapeutic applications. Chalcones are characterized by their accessible preparation and chemical versatility, making them a focal point for research in drug development. This text aims to provide both novice and experienced researchers with the foundational knowledge necessary to advance their work in this area. The book is organized into three parts. Part I, “Foundations of Chalcones Research,” covers the natural sources of chalcones, various extraction methods, structural characterization techniques, synthesis, and their role in organic chemistry and metal complexes. Part II, “Pharmacology of Chalcones,” addresses pharmacokinetic properties, toxicity, and the medicinal uses of chalcones, including their effectiveness against viruses, bacteria, cancer, and neurodegenerative diseases. Part III, “Prospects,” explores chalcone-containing products, drug formulation strategies, and clinical trials involving chalcone-based drug candidates. This reference is an essential resource for pharmaceutical researchers, providing critical insights into the applications and potential of chalcones in drug development and therapeutic interventions.

    • The Story of GLP-1

      • 1st Edition
      • March 1, 2026
      • Jens Juul Holst
      • English
      • Hardback
        9 7 8 0 4 4 3 3 3 2 8 7 6
      • eBook
        9 7 8 0 4 4 3 3 3 2 8 8 3
      The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity is a critically acclaimed account detailing the groundbreaking discovery of the hormone GLP-1, narrated by the award-winning scientist Professor Jens Juul Holst, along with co-authors Professor Sten Madsbad, Professor Jens Meldgaard Bruun, and Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation. GLP-1 is the hormone found in weight loss medications and diabetes treatments such as Ozempic and Wegovy. The discovery of GLP-1 has significantly transformed treatment options for individuals with type 2 diabetes and obesity, offering benefits that include improved blood glucose regulation and substantial weight loss, while also lowering the risk of related complications. Professor Jens Juul Holst, MD, DMSc, is among the world's leading diabetes researchers, having pioneered the discovery of GLP-1 in the 1980s. In this book, we follow the historical research journey that led to the identification of this hormone, which now signifies a paradigm shift in the management of diabetes and obesity. "The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity" narrates the rising rates of obesity and diabetes, underscoring a critical public health issue, even in light of considerable progress in treatment alternatives. While traditional approaches, such as low-calorie diets, have shown potential for short-term weight loss, maintaining that loss has proven difficult. Efforts to achieve better blood sugar control have not consistently translated into reduced complications or improved patient outcomes, as demonstrated by extensive international studies. However, the introduction of new diabetes medications, particularly those based on glucagon-like peptide-1 (GLP-1), such as liraglutide and semaglutide, has marked a significant breakthrough. These medications not only improve blood sugar levels but also promote substantial weight loss and reduce cardiovascular complications, offering hope for better management of obesity and diabetes. Despite these promising results, challenges remain regarding accessibility and affordability of these treatments, raising important societal questions about who should receive them and how they should be funded. The author's involvement in the discovery and development of GLP-1 provides a unique perspective on the historical and physiological context of these advancements, making this book a valuable resource for understanding the complexities of metabolic diseases and the evolution of treatment options.

    • Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies

      • 1st Edition
      • March 1, 2026
      • Shuvomoy Banerjee + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 5 7 1 7 3
      • eBook
        9 7 8 0 4 4 3 4 5 7 1 8 0
      Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies addresses the critical challenge of cancer chemoresistance, synthesizing insights from cancer biology, molecular biology, biotechnology, and nanotechnology. This book explores the complex mechanisms underlying drug resistance, including alterations in key signaling pathways and the tumor microenvironment's role in cancer cell survival. It highlights advancements in drug delivery technologies, such as nanomedicine and biomimetic strategies, which enhance drug targeting and minimize off-target effects. The integration of techniques like CRISPR-Cas9 and artificial intelligence in developing next-generation therapies is also emphasized. For an academic audience, this book serves as an essential resource to foster interdisciplinary collaboration in cancer research. It equips researchers, clinicians, and industry professionals with the knowledge needed to navigate the evolving landscape of cancer therapeutics, addressing critical challenges in drug delivery and chemoresistance to improve patient outcomes.

    • Handbook of Material Biodegradation, Biodeterioration, and Biostablization

      • 3rd Edition
      • March 1, 2026
      • George Wypych + 2 more
      • English
      • Hardback
        9 7 8 1 7 7 4 6 7 0 8 8 0
      • eBook
        9 7 8 1 7 7 4 6 7 0 8 9 7
      Handbook of Material Biodegradation, Biodeterioration, and Biostabilization, Third Edition provides extensive information on the microorganisms involved in the biodegradation of materials, along with the biocides which are permitted for use according to the most up-to-date worldwide legislation. The book focuses on protecting materials and products against colonization and subsequent degradation of their properties. Mechanisms of biodegradation and biodeterioration, results of biodeterioration, and methods of biostabilization are covered for a large number of products, making the title relevant for a range of industries and applications, including construction, coatings/paints, medical and pharmaceutical applications, and electronics. It also covers 13 groups of bacteria, 7 groups of fungi, and 4 groups of protozoa involved in biodegradative processes. In addition, the health and safety aspects of biocide application are covered in detail, as well as the personal protection of practitioners who are required to use them. The contents and the most-up-to-date information make this book essential for almost all the fields of applied chemistry.

    • Stem Cell-Mediated Regulation of Pyroptosis

      • 1st Edition
      • March 1, 2026
      • Debalina Bhattacharya + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 0 4 7 1 9
      • eBook
        9 7 8 0 4 4 3 4 0 4 7 2 6
      Stem Cell-Mediated Regulation of Pyroptosis investigates the role of pyroptosis in various types of stem cells and stem cell-derived exosomes, considering how they can accelerate tissue repair and regeneration in inflammatory diseases. The book begins with an introduction to the mechanisms of pyroptosis and methods available for its detection. It then considers pyroptosis and its relationship to stem cells, before delving into this interaction across various conditions ranging from cerebral injury, spinal injury and cardiac injury to osteoarthritis, cancer, and many more. This book delves into the latest research findings and future directions in the study of stem cells and pyroptosis, enabling readers to understand the cellular mechanisms underlying this form of cell death and the clinical significance of stem cells in the context of pyroptosis-induced diseases. It considers therapeutic implications and potential strategies targeting this pathway for the treatment of such conditions, providing a comprehensive reference that will be useful to researchers working across cell biology, regenerative medicine, immunology, therapeutics and other related fields.

Related subjects

Agricultural and biological sciences

Drug discovery

Immunology

Microbiology and virology

Neuroscience

Pharmaceutical sciences

Pharmacology

Toxicology